MOBI Mobia Medical, Inc. - Common Stock
$13.65
Price · Jul 2, 2026
Fundamentals as of Jun 4, 2026
52W Range
$10–$15
68% of range
Analyst Rating
—
Price Target
$20
+47% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
MOBI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$13.65
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$10 – $15
MOBI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MOBI
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MOBI
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MOBI
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
MOBI
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MOBI
Peer Median
MOBI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
5 analysts · 2026-06-29
Median
$19.00
← Below all targets
$13.65
Low
$15.00
High
$31.00
Median target
$19.00
+39.2%
Mean target
$20.00
+46.5%
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MOBI | — | — | — | — | — | — |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| ANGO | $418M | -12.3 | -3.8% | -11.6% | -18.4% | 53.9% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 16
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $12M | $6M | |
| Cost of Revenue | $2M | $1M | |
| Gross Profit | $10M | $5M | |
| R&D Expense | $2M | $1M | |
| SG&A Expense | $25M | $14M | |
| Operating Expenses | $27M | $15M | |
| Operating Income | $-17M | $-10M | |
| Other Non-op | $282.0K | $-109.0K | |
| Pretax Income | $-18M | $-11M | |
| Income Tax | $0 | $1.0K | |
| Net Income | $-18M | $-11M | |
| EPS (Basic) | $-19.30 | $-12.97 | |
| EPS (Diluted) | $-19.30 | $-12.97 | |
| Shares (Basic) | 918,935 | 821,160 | |
| Shares (Diluted) | 918,935 | 821,160 | |
| EBITDA | $-17M | · |
Balance Sheet 17
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $56M | · | |
| Receivables | $5M | · | |
| Inventory | $6M | · | |
| Other Current Assets | $2M | · | |
| Current Assets | $72M | · | |
| PP&E (Net) | $738.0K | · | |
| Other Non-current Assets | $143.0K | · | |
| Total Assets | $74M | · | |
| Accounts Payable | $3M | · | |
| Current Liabilities | $12M | · | |
| Capital Leases | $870.0K | · | |
| Total Liabilities | $62M | · | |
| Common Stock | $10.0K | · | |
| Retained Earnings | $-176M | · | |
| Stockholders' Equity | $-168M | · | |
| Liabilities + Equity | $74M | · | |
| Shares Outstanding | 1,003,256 | · |
Cash Flow 8
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $56.0K | $31.0K | |
| Stock-based Comp | $407.0K | $201.0K | |
| Operating Cash Flow | $-18M | $-10M | |
| CapEx | $42.0K | $23.0K | |
| Investing Cash Flow | $-42.0K | $-23.0K | |
| Financing Cash Flow | $40M | $32M | |
| Net Change in Cash | $22M | $23M | |
| Free Cash Flow | $-18M | · |
Profitability 8
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Gross Margin | 82.3% | · | |
| Operating Margin | -140.3% | · | |
| Net Margin | -146.9% | · | |
| Pretax Margin | -146.9% | · | |
| EBITDA Margin | -140.3% | · | |
| ROA | -48.2% | · | |
| ROE | 21.1% | · | |
| ROIC | 10.1% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 6.1 | · | |
| Quick Ratio | 5.1 | · |
Efficiency 3
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.3 | · | |
| Inventory Turnover | 0.7 | · | |
| Receivables Turnover | 5.0 | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.